BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 365547)

  • 1. Cell-mediated immunity to myelin basic protein in Lewis rats made unresponsive to experimental allergic encephalomyelitis.
    McGraw TP; Swanborg RH
    Eur J Immunol; 1978 Dec; 8(12):905-9. PubMed ID: 365547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats.
    Holda JH; Swanborg RH
    Eur J Immunol; 1981 Apr; 11(4):338-40. PubMed ID: 6166483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of experimental allergic encephalomyelitis by bacterial lipopolysaccharides: inhibition of cell-mediated immunity.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1981 Jul; 127(1):13-6. PubMed ID: 6165758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IgM repertoire reactions to MBP/CFA immunization reflect the individual status of EAE susceptibility.
    Fesel C; Coutinho A
    J Autoimmun; 2000 Jun; 14(4):319-24. PubMed ID: 10882058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis.
    Swierkosz JE; Swanborg RH
    J Immunol; 1975 Sep; 115(3):631-3. PubMed ID: 50370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
    Hinrichs DJ; Roberts CM; Waxman FJ
    J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental allergic encephalomyelitis in Lewis rats: inhibition by bacterial lipopolysaccharides and acquired resistance to reinduction by challenge with myelin basic protein.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1981 Jul; 127(1):16-20. PubMed ID: 6165759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic neurologic dysfunction and demyelination induced in Lewis rats by repeated injections of encephalitogenic T-lymphocyte lines.
    Vandenbark AA; Nilaver G; Konat G; Teal P; Offner H
    J Neurosci Res; 1986; 16(4):643-56. PubMed ID: 2432277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines.
    Ben-Nun A; Cohen IR
    J Immunol; 1982 Mar; 128(3):1450-7. PubMed ID: 6173439
    [No Abstract]   [Full Text] [Related]  

  • 11. A quantitative assay for experimental allergic encephalomyelitis in the rat based on permeability of spinal cords to 125I-human gamma-globulin.
    Stohl W; Kaplan MS; Gonatas NK
    J Immunol; 1979 Mar; 122(3):920-5. PubMed ID: 87421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental allergic encephalitis: study of cellular immunity during disease suppression.
    von Muller CS; Spitler LE; LeCocq J
    Eur J Immunol; 1978 Nov; 8(11):771-6. PubMed ID: 82509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
    Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A.
    Panitch HS; McFarlin DE
    J Immunol; 1977 Sep; 119(3):1134-7. PubMed ID: 302272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH; Silberg D; Swanborg RH
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
    Killen JA; Swanborg RH
    J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease.
    Welch AM; Holda JH; Swanborg RH
    J Immunol; 1980 Jul; 125(1):186-9. PubMed ID: 6155396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of experimental allergic encephalomyelitis in suckling Lewis rats: role of age and type of sensitizing neuroantigen.
    Fujinami RS; Paterson PY
    J Immunol; 1977 Nov; 119(5):1634-8. PubMed ID: 72104
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
    Kennedy MK; Tan LJ; Dal Canto MC; Tuohy VK; Lu ZJ; Trotter JL; Miller SD
    J Immunol; 1990 Feb; 144(3):909-15. PubMed ID: 1688591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.